‘R&D continues to be the key driver for sustained growth’—Kushal Suri, Head International Business Development, Morepen Laboratories Read more
By 2030, we want to treat one in five cancer patients in India: Lara Bezerra, MD Roche India Read more
‘Our turnover has grown 65 per cent in comparison to 2015-16. We are looking to grow 40 per cent this year’ Read more